Healthcare >> CEO Interviews >> September 23, 2003
DONALD (GUY) SEATON joined Corus Pharma Inc. in May 2002 as Chief
Financial Officer. With 20 years of financial and operation experience,
Mr. Seaton has significant experience and leadership in raising capital,
acquisitions and IPO preparations. For the past 12 years, Mr. Seaton has
focused on financial management for pre-IPO and early-stage companies.
Most recently he was CFO at Talisma Corporation, a privately held
enterprise software company where he managed three rounds of private
equity totaling $54 million. Prior to Talisma, he was CFO and COO for
SonoSite, Inc., a publicly traded ultrasound company, where he raised
$64 million, including the company's IPO. Prior to that, he was CFO at
InControl, Inc., developer of the world's first implantable atrial
defibrillator. He managed the company's IPO as well as several follow-on
equity offerings. Mr. Seaton received an MBA from the University of
Chicago and an undergraduate degree in Economics from Stanford
University. Profile
Pharma?
Mr. Seaton: Corus was founded by
Dr. Bruce Montgomery in Seattle in January 2001, approximately five
months after
